C4 Therapeutics (CCCC) EBT (2019 - 2026)
C4 Therapeutics' quarterly EBT came in at -$25.1 million in Q1 2026, up 4.53% year-on-year from -$24.0 million in Q1 2025, and down 23.39% quarter-over-quarter from -$20.4 million in Q4 2025.
C4 Therapeutics has reported EBT for 8 years, with the latest figure at -$25.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 4.53% year-over-year to -$25.1 million; the trailing twelve-month figure through Mar 2026 stood at -$103.7 million (down 0.52% YoY), and the FY2025 full-year result was -$104.9 million, changed 0.3% from the prior year.
- EBT for Q1 2026 stood at -$25.1 million, down from -$20.4 million in the prior quarter.
- The five-year high for EBT was -$17.7 million in Q2 2024, with the low at -$37.2 million in Q4 2022.
- Average EBT over 5 years is -$29.1 million, with a median of -$28.4 million recorded in 2024.
- Year-over-year, EBT tumbled 137.48% in 2022 and surged 50.68% in 2024.
- Tracing CCCC's EBT over 5 years: stood at -$37.2 million in 2022, then grew by 7.28% to -$34.5 million in 2023, then rose by 0.1% to -$34.4 million in 2024, then soared by 40.87% to -$20.4 million in 2025, then dropped by 23.39% to -$25.1 million in 2026.
- The last three EBT figures came in at -$25.1 million (Q1 2026), -$20.4 million (Q4 2025), and -$32.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | C4 Therapeutics | 561.03 Mn | 325.36 Mn | - | -25.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.13 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Sep 30, 2025 | -32.17 Mn |
| Jun 30, 2025 | -26.02 Mn |
| Mar 31, 2025 | -26.32 Mn |
| Dec 31, 2024 | -34.44 Mn |
| Sep 30, 2024 | -24.67 Mn |
| Jun 30, 2024 | -17.72 Mn |
| Mar 31, 2024 | -28.36 Mn |
| Dec 31, 2023 | -34.48 Mn |
| Sep 30, 2023 | -26.03 Mn |
| Jun 30, 2023 | -35.92 Mn |
| Mar 31, 2023 | -34.78 Mn |
| Dec 31, 2022 | -37.19 Mn |
| Sep 30, 2022 | -31.96 Mn |
| Jun 30, 2022 | -26.88 Mn |
| Mar 31, 2022 | -31.62 Mn |
| Dec 31, 2021 | -15.66 Mn |
| Sep 30, 2021 | -24.68 Mn |
| Jun 30, 2021 | -22.58 Mn |
| Mar 31, 2021 | -20.97 Mn |
| Dec 31, 2020 | -21.92 Mn |
| Sep 30, 2020 | -22.00 Mn |
| Jun 30, 2020 | -10.96 Mn |
| Mar 31, 2020 | -12.08 Mn |
| Dec 31, 2019 | -10.12 Mn |
| Sep 30, 2019 | -9.44 Mn |